Share

October 2022; 12 (5) Research Article

Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study

Sana Aslam, Nan Zhang, Charles H. Adler, Thomas G. Beach, Erika Driver-Dunckley, Shyamal H. Mehta, Holly Shill
First published September 9, 2022, DOI: https://doi.org/10.1212/CPJ.0000000000200072
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
84

Share

Article Information

vol. 12 no. 5 e85-e92
DOI: 
https://doi.org/10.1212/CPJ.0000000000200072
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received July 21, 2021
  • Accepted July 19, 2022
  • First Published September 9, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Sana Aslam, DO,
    2. Nan Zhang, PhD,
    3. Charles H. Adler, MD, PhD,
    4. Thomas G. Beach, MD, PhD,
    5. Erika Driver-Dunckley, MD,
    6. Shyamal H. Mehta, MD, PhD and
    7. Holly Shill, MD
  1. Sana Aslam, DO,
    2. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Nan Zhang, PhD,
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Charles H. Adler, MD, PhD,
    4. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Acorda, Amneal, Axovant, Cionic, Eisai, Jazz, Neurocrin

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS, 1U01NS093334-01, investigator, 2015-Present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation for Parkinson's Disease <br>Research

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. Cionic, 2020-2022

    Legal Proceedings:

    1. NONE

  4. Thomas G. Beach, MD, PhD,
    5. Scientific Advisory Boards:

    1. 1) Scientific advisory board for Vivid Genomics

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1) Speaker honorarium from World Parkinson Coalition

    Editorial Boards:

    1. 1) Editorial board, Journal of Alzheimer's Disease<br>2) Editorial board, Journal of Neuropathology and Experimental <br>Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. I have been employed since 1997 solely with the non-<br>profit organizations Sun Health Research Institute and <br>Banner Health.

    Consultancies:

    1. 1) Vivid Genomics <br>2) Acadia Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Avid Radiopharmaceuticals

    Research Support, Government Entities:

    1. 1) National Institute on Aging P30 AG19610, Co-Investigator, <br>2001 - present<br>2) National Institute of Neurological Disorders and Stroke, <br>R01 NS118669, 2021 - present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Michael J. Fox Foundation for Parkinson&#x0092;s Research<br>2) Sun Health Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. 1) Vivid Genomics, Inc, stock option

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. Vivid Genomics

    Stock/Stock Options, Medical Equipment & Materials:

    1. Vivid Genomics

    Legal Proceedings:

    1. NONE

  5. Erika Driver-Dunckley, MD,
    6. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Shyamal H. Mehta, MD, PhD and
    7. Scientific Advisory Boards:

    1. Attended Advisory Board Meeting:<br>1) AbbVie <br>2) Abbott Inc<br>3) Adamas Pharmaceuticals

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1) AbbVie <br>2) Abbott<br>3) Adamas Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) AbbVie <br>2) Abbott<br>3) Adamas Pharmaceuticals

    Research Support, Government Entities:

    1. Arizona Biomedical Research Consortium

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. International Essential Tremor Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Holly Shill, MD
    8. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Abbvie, Biogen, Amneal, Acorda, Neurocrine

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Dr. Shill has research support from Transposon, Saccadous, US <br>World Meds/Supernus, Cavion, Cerevel, Impax.

    Research Support, Government Entities:

    1. NINDS/NIH. NN110: A Dose Selection Trial of Light Therapy <br>for Impaired Sleep in Parkinson&#x0092;s Disease. Oct. 2020-<br>present. Role: Local PI.<br>NINDS/NIH. Network for Excellence in Neuroscience <br>Clinical Trials (NeuroNEXT). 9/2018-present. Role: Co-PI. <br>10% FTE.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J Fox Foundation for Parkinson Research<br>Barrow Neurological Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (SA, HS), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (NZ, CHA, ED-D, SHM), Mayo Clinic, Scottsdale, AZ; and Banner Sun Health Research Institute (TGB), Sun City, AZ.
  1. Correspondence
    Dr. Aslam sana.aslam{at}barrowneuro.org

Article usage

Article usage: September 2022 to October 2023

AbstractFullPdfSource
Sep 2022553018Highwire
Oct 20226515526Highwire
Nov 20223172111Highwire
Dec 202217488Highwire
Jan 202397105Highwire
Feb 20239843Highwire
Mar 20239943Highwire
Apr 20235310Highwire
May 20233421Highwire
Jun 20233802Highwire
Jul 20236310Highwire
Aug 20235736Highwire
Sep 20235411Highwire
Oct 20238100Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me